[mTOR and non-small cell lung cancer]

Zhongguo Fei Ai Za Zhi. 2010 Jan;13(1):69-72. doi: 10.3779/j.issn.1009-3419.2010.01.13.

[Article in Chinese]

Authors

Liang Wang¹, Shaofa Xu, Wentao Yue

Affiliation

¹ Department of Cellular and Molecular Biology, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China.

PMID: 20672708
PMCID: PMC6000679
DOI: 10.3779/j.issn.1009-3419.2010.01.13

No abstract available

Publication types

Review

MeSH terms

Animals
Carcinoma, Non-Small-Cell Lung / drug therapy
Carcinoma, Non-Small-Cell Lung / metabolism*
Humans
Intracellular Signaling Peptides and Proteins / antagonists & inhibitors
Intracellular Signaling Peptides and Proteins / metabolism*
Lung Neoplasms / drug therapy
Lung Neoplasms / metabolism*
Protein Serine-Threonine Kinases / antagonists & inhibitors
Protein Serine-Threonine Kinases / metabolism*
Signal Transduction / drug effects
Sirolimus / therapeutic use
TOR Serine-Threonine Kinases

Substances

Intracellular Signaling Peptides and Proteins
MTOR protein, human
Protein Serine-Threonine Kinases
TOR Serine-Threonine Kinases
Sirolimus